Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10063742 | 0.79 | LMNA (0.48) | LMNAALDH1A1TP53TSHRCA1 | |
| SCHEMBL46361 | 0.75 | KMT2A (0.34) | LMNAALDH1A1TP53TSHRCYP2C9 | |
| Water SCHEMBL31387323 | 0.73 | ALDH1A1 (0.33) | LMNAALDH1A1TP53TSHRCYP2C9 | |
| SCHEMBL4134507 | 0.70 | LMNA (0.48) | LMNAALDH1A1TP53TSHRCA1 | |
| SCHEMBL31163780 | 0.70 | LMNA (0.46) | LMNAALDH1A1TP53TSHRCA1 | |
| SCHEMBL5528579 | 0.70 | CRBN (0.40) | LMNAALDH1A1CYP2C9GAAL3MBTL1 | |
| SCHEMBL13276962 | 0.68 | TRIM24 (0.39) | LMNAALDH1A1CYP2C9GAAL3MBTL1 | |
| SCHEMBL31715737 | 0.68 | GAA (0.33) | ALDH1A1CYP2C9GAAL3MBTL1POLB | |
| SCHEMBL2650564 | 0.67 | POLB (0.31) | LMNATP53L3MBTL1POLBKDM4E | |
| SCHEMBL6594728 | 0.67 | POLB (0.31) | LMNATP53L3MBTL1POLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116854899-A | Flexible high polymer material with self-repairing performance and preparation method thereof | 暨南大学 | 2023-10-10 | — | — | CN | claimed |
| CN-116790126-A | Flexible high polymer material with glucose response, preparation method thereof and application thereof in preparation of biosensor | 暨南大学 | 2023-09-22 | — | — | CN | claimed |
| CN-113057909-B | Intelligent thermotropic hydrogel skin care film and preparation method and application thereof | 复旦大学 | 2022-10-18 | — | — | CN | claimed |
| CN-111548482-B | Nitric oxide donor modified copolymer, sustained-release preparation containing nitric oxide donor modified copolymer, and preparation method and application of nitric oxide donor modified copolymer | 复旦大学 | 2022-09-13 | — | — | CN | claimed |
| CN-112250888-B | X-ray development thermotropic hydrogel and preparation method and application thereof | 复旦大学 | 2022-04-01 | — | — | CN | claimed |
| CN-112043827-B | Thermo-sensitive pharmaceutical composition, transdermal preparation, and preparation method and application thereof | 复旦大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-116854899-A | Flexible high polymer material with self-repairing performance and preparation method thereof | 暨南大学 | 2023-10-10 | — | — | CN | disclosed |
| CN-116854899-A | Flexible high polymer material with self-repairing performance and preparation method thereof | 暨南大学 | 2023-10-10 | — | — | CN | disclosed |
| CN-116790126-A | Flexible high polymer material with glucose response, preparation method thereof and application thereof in preparation of biosensor | 暨南大学 | 2023-09-22 | — | — | CN | disclosed |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| CN-113057909-B | Intelligent thermotropic hydrogel skin care film and preparation method and application thereof | 复旦大学 | 2022-10-18 | — | — | CN | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305300-A1 | Method of Ring-Opening Polymerization, and Related Compositions and Articles | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305300-A1 | Method of Ring-Opening Polymerization, and Related Compositions and Articles | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| CN-101864065-A | Biodegradable amphiphilic block copolymer containing cyclic ether side group and preparation method and applications thereof | UNIV TIANJIN | 2010-10-20 | — | — | CN | disclosed |
| US-6348564-B1 | UNSUBSTITUTED OXEPANE-DIONES PREPARED BY OXIDATION OF CYCLOHEXANEDIONES; BIOCOMPATIBILITY, BIODEGRADATION, NONTOXIC | SOLVAY (SOCIETE ANONYME) (BE) | 2002-02-19 | — | — | US | disclosed |
| EP-1061079-A1 | Cyclic esterketone compounds and processes for the synthesis and use thereof | SOLVAY (Société Anonyme) (BE) | 2000-12-20 | — | — | EP | disclosed |
| EP-1061078-A1 | Cyclic esterketone compounds, processes for the synthesis thereof and process for the preparation of poly(esterketone)polymers | SOLVAY (Société Anonyme) (BE) | 2000-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | PUF60, CAPG, GMPS | LMNA 4337/4885ALDH1A1 4488/4885TP53 1207/4885 |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | PFAS, PAM, PCNA | LMNA 1875/4885ALDH1A1 618/4885TP53 4006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.